Cargando…
Anti-tumor activity of splice-switching oligonucleotides
Alternative splicing has emerged as an important target for molecular therapies. Splice-switching oligonucleotides (SSOs) modulate alternative splicing by hybridizing to pre-mRNA sequences involved in splicing and blocking access to the transcript by splicing factors. Recently, the efficacy of SSOs...
Autores principales: | Bauman, John A., Li, Shyh-Dar, Yang, Angela, Huang, Leaf, Kole, Ryszard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001088/ https://www.ncbi.nlm.nih.gov/pubmed/20719743 http://dx.doi.org/10.1093/nar/gkq731 |
Ejemplares similares
-
Design principles for bifunctional targeted oligonucleotide enhancers of splicing
por: Owen, Nicholas, et al.
Publicado: (2011) -
Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells
por: Palhais, Bruno, et al.
Publicado: (2015) -
Small antisense oligonucleotides against G-quadruplexes: specific mRNA translational switches
por: Rouleau, Samuel G., et al.
Publicado: (2015) -
Recognition of RNA duplexes by chemically modified triplex-forming oligonucleotides
por: Zhou, Yuan, et al.
Publicado: (2013) -
Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing
por: Nojima, Takayuki, et al.
Publicado: (2009)